Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niuliva for prevention of HBV recurrence after liver transplant
NCT01131065Phase 3Completed
- Sponsor
- Grifols
- Start
- Jul 2010
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by Grifols. Started Jul 2010; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01131065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131065.